FINDING NOVEL REAGENTS BY BIOINFORMATICS AND BIOCHEMISTRY

Information

  • Research Project
  • 8488588
  • ApplicationId
    8488588
  • Core Project Number
    R44GM100560
  • Full Project Number
    4R44GM100560-02
  • Serial Number
    100560
  • FOA Number
    PA-11-096
  • Sub Project Id
  • Project Start Date
    3/5/2012 - 12 years ago
  • Project End Date
    9/9/2014 - 9 years ago
  • Program Officer Name
    MAAS, STEFAN
  • Budget Start Date
    9/10/2012 - 11 years ago
  • Budget End Date
    9/9/2013 - 10 years ago
  • Fiscal Year
    2012
  • Support Year
    02
  • Suffix
  • Award Notice Date
    9/10/2012 - 11 years ago

FINDING NOVEL REAGENTS BY BIOINFORMATICS AND BIOCHEMISTRY

DESCRIPTION (provided by applicant): This project aims to find novel restriction enzymes that will be useful in many aspects of molecular biology research. One particular focus will be on restriction endonucleases that are able to recognize modified DNA, especially DNA containing 5-methylcytosine and 5- hydroxymethycytosine since such enzymes have many potential applications in epigenetics research. Enzymes recognizing these modified bases are known to occur in bacterial and archaea strains and in the past, many have been found by random biochemical screening. In the proposed project, the discovery of potential new enzymes will use bioinformatics techniques and take advantage of the large number of currently sequenced prokaryotic genomes, both completely sequenced genome and shotgun sequences. The project will identify good candidates and then use biochemical methods to characterize them. In addition to commercializing any useful enzymes that are found from this screen, the information gained about the biochemical function of the restriction enzymes discovered will be invaluable for genome annotation and will have practical implications for researchers working with pathogenic organisms. The latter will result from our efforts to characterize the restriction-modification systems in pathogens and identify those systems which need either to be knocked out or circumvented by prior modification prior to transformation. Thus, the results of this research will have immediate implications for the fields of epigenetics, pathogenesis and genome annotation.

IC Name
NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
  • Activity
    R44
  • Administering IC
    GM
  • Application Type
    4
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    437446
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    859
  • Ed Inst. Type
  • Funding ICs
    NIGMS:437446\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    NEW ENGLAND BIOLABS, INC.
  • Organization Department
  • Organization DUNS
    066605403
  • Organization City
    IPSWICH
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    019382723
  • Organization District
    UNITED STATES